Medline INC Form 4 insider transactions

GIC Private Ltd and 2 others reported changes in beneficial ownership of Medline Inc. common stock on August 7, 2026.

Executive Vice President William J. Abrams reported the withholding of 1,308 shares of Medline Inc. common stock to satisfy tax obligations related to restricted stock unit vesting.

Medline Inc. Chief Human Resources Officer Christopher P. Shryock reported a transaction involving Class A Common Stock, with shares withheld for tax liabilities.

Medline Inc. Chief Operating Officer Stephen L. Miller reported a disposition of Class A Common Stock to cover tax liabilities.

Alexander M. Liberman, Chief Legal Officer of Medline Inc., reported a transaction involving the sale of Class A Common Stock to cover tax liabilities.

Medline Inc. Chief Product Officer Amanda H. Laabs reported a disposition of Class A Common Stock.

Michael B. Drazin, Chief Financial Officer of Medline Inc., reported a disposition of Class A Common Stock on June 15, 2026, to cover tax liabilities.

Douglas P. Golwas reports significant transactions in Medline Inc. Class A and Class B common stock, including sales under a 10b5-1 plan and exchanges of LP units.

Medline Inc. reports a transaction where CEO James M. Boyle sold Class A Common Stock to cover tax liabilities upon vesting of restricted stock units.

Director Richard Galanti acquired 5,387 restricted stock units in Medline Inc. as part of an equity grant.

Director Thomas W. Sweet disclosed the acquisition of restricted stock units in Medline Inc. as part of equity compensation.

Director Todd M. Bluedorn acquired 15,732 shares of Medline Inc. Class A Common Stock through restricted stock unit grants.

Jessi L. Corcoran, an officer at Medline Inc., reported a transaction involving the sale of 5,000 shares of Class A Common Stock.

Hellman & Friedman entities sold approximately 30.87 million shares of Medline Inc. common stock as part of an underwritten public offering.

Director Patrick J. Healy reported a distribution in kind of Medline Inc. Class A common stock resulting in increased direct and indirect holdings.

Blackstone-affiliated entities report significant transactions involving Medline Inc. Class A Common Stock, including sales and in-kind distributions.

Several Blackstone-affiliated entities have reported transactions related to their beneficial ownership of Medline Inc. Class A and Class B common stock, as well as common units of Medline Holdings, LP.

SEC Form 4 filing details significant transactions and beneficial ownership changes related to Medline Inc. Class A and Class B common stock by various Blackstone entities.

Medline Inc. Director Patrick J. Healy reported an increase in his direct and indirect beneficial ownership of Class A Common Stock through a distribution in kind from Hellman & Friedman entities.

Hellman & Friedman entities, a 10% owner and director of Medline Inc., sold over 26 million shares of Class A Common Stock in a secondary public offering and distributed additional shares to partners.

Carlyle Group Inc. and its affiliates reported the sale of over 26 million shares of Medline Inc. Class A Common Stock for $41 per share and a pro-rata distribution of over 2 million shares.

Blackstone-affiliated entities and Stephen A. Schwarzman reported significant sales and in-kind distributions of Medline Inc. Class A Common Stock in connection with a secondary offering.

Blackstone-affiliated entities reported significant sales and in-kind distributions of Medline Inc. Class A Common Stock totaling over 28 million shares at $40.508 per share.

Carlyle Group entities converted over 9 million Medline Holdings LP Common Units into Medline Inc. Class A Common Stock across two transactions in early March 2026.

Carlyle-affiliated entities converted over 9 million Medline Holdings LP Common Units into Medline Inc. Class A Common Stock across two transactions in early March 2026.

Carlyle Group entities converted over 9 million Medline Holdings LP Common Units into Medline Inc. Class A Common Stock across two transactions in early March 2026.

Carlyle-affiliated entities converted over 9 million Medline Holdings LP Common Units into Medline Inc. Class A Common Stock across two transactions in early March 2026.

Hellman & Friedman entities converted over 15 million Medline Common Units into Class A Common Stock, leading to the cancellation of an equivalent number of Class B shares.

Medline Inc.'s Chief Commercial Officer, Douglas P. Golwas, reported significant acquisitions of Class B Common Stock, Common Units, and Incentive Units related to the company's IPO reclassification, alongside a new grant of restricted stock units.

Medline Executive Vice President William J. Abrams reported the reclassification of equity interests and a new restricted stock unit grant, primarily linked to the company's IPO.